Skip to content
Saturday 29 August 2026London --:--Frankfurt --:--Zurich --:--
NewslettersSearchEN · DE · FR
MorningWire

European business, markets and politics

FTSE 100
10,824.26
+0.29%
DAX
26,569.99
+0.77%
CAC 40
8,401.18
+0.98%
STOXX 50
6,485.67
+0.95%
  • Europe
  • Markets
  • Business
  • Economy
  • Regulation
  • Politics
  • Opinion
More
GermanyFranceEU InstitutionsCompetitionPublic AffairsBankingTechnologyEnergy
  • Germany
  • France
  • Europe
  • Markets
  • Business
  • Economy
  • Regulation
  • Politics
  • Opinion
  • DE
Sunday 23 August 2015 11:08 pm

British American Tobacco to put its first quitting aid Voke on the market

By: Express KCS

Add as a preferred source on Google

British American Tobacco’s (BAT) first anti-smoking product, Voke, will arrive in shops at the end of the year, marking a victory for BAT over its rivals such as Imperial Tobacco who have similar products in development.

BAT was granted regulatory approval in 2014 by the Medicines and Healthcare Products Regulatory Agency (MHPRA).

The product will be the first approved quitting aid made by a tobacco company.

An MHPRA spokesperson said: “The MHPRA continues to encourage and actively support companies to submit medicines licence applications for electronic cigarettes and other nicotine containing products, which can be used in stop smoking services.”

Share this article

  • Facebook
  • X
  • LinkedIn
  • WhatsApp
  • Email

Similarly tagged content:

Sections

  • Markets & Economics

Categories

  • Markets

Related Topics

  • British American Tobacco
  • Company

Trending Articles

  • Pensioners to hand over bank statements in government benefits crackdown

  • Jamie Carragher: HMRC petitions for Sky Sports star to be declared bankrupt

  • Brewdog founder James Watt hits out at ‘total silence’ over new venture

  • Lloyds Bank and Halifax users unable to use app in latest outage

  • As it happened: FTSE 100 falls but Nasdaq soars after Nvidia sales boom

More from Morning Wire

  • Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma

    Business Wire
  • As it happened: FTSE 100 jumps as oil falls back; Warsh says ‘work to do’ on inflation

    FTSE 100 Live
  • Banning vape shops won’t fix scuzzy high streets

    Opinion
    High street vape shop Ecigwizard next to Costa Coffee and Subway, with people walking and sitting outside.
  • Meta trial risks reputational damage that ‘dwarfs’ financial hit

    Tech
    Mark Zuckerberg in a dark suit, looking intently with a red light blurred in the background
  • Daiichi Sankyo Appoints Markus Kosch to Lead Europe Business as Part of New Commercialization Organization

    Business Wire
  • Zilch, Clearscore among five UK scale-ups to get dedicated FCA support

    Tech
    PhilandSean ZilchCo founders discussing business strategy in an office setting, highlighting innovative leadership and tea...
  • Summer loving! 9 amazing things to do in London this August

    Life&Style
    Three revelers in vibrant feathered costumes celebrating at Notting Hill Carnival.
  • U.S. FDA approves ViiV Healthcare’s Tivicay PD, helping close a critical HIV treatment gap for young children

    Business Wire
MorningWire

Independent European business, markets and political news for decision-makers.

Morning Briefing

Europe

  • Germany
  • France
  • EU Institutions
  • Europe

Business

  • Markets
  • Business
  • Economy
  • Regulation
  • Competition
  • Public Affairs

Editorial

  • Opinion
  • Editorial Policy
  • Corrections
  • Contact

Company

  • About Morning Wire
  • Privacy Policy
  • Terms of Use
  • Cookie Policy
© 2026 Morning Wire Ltd · Published by Morning Wire Media, Bahnhofstrasse 65, 8001 Zürich, Switzerland
Privacy · Terms · Cookies · Facebook